|
 |
 |
| 동상은 비판받았던 사람들을 위해 세워진다 |
수많은 동상들은
살아있을 때 비판을 받아왔던 사람들을 위해 세워진 것이다.
그러나 비판을 해왔던 사람들을 위해 세워진 동상은 없다.
사람들이 당신에 대해 수근 거리는 것을 멈추는 그날이 바로
당신이 성장을 멈추고 '정상적인 사람'이 되는 날이다.
by 강문국 선생님
|
Wednesday, April 14, 2010 8:00am 5:30pm
Orlando, Florida
|
| | |
 |
CO-CHAIRMEN:
Dipnarine Maharaj, MD, MBChB, FRCP, FRCPath, FACP,
Director, South Florida Bone Marrow/Stem Cell Transplant Institute
Stephen Holt MD, PhD, DSc, LLD(Hon.) DNM, ChB, FRCP (C), MRCP (UK), FACP, FACG, FACN, FACAM, KSJ, Distinguished Professor of Medicine (Emerite), Advisor Natural Clinician, LLC |
| | |
| |
COURSE DESCRIPTION:
In the past decade, stem cell research and treatments have attracted more media interest than any other branch of medical practice. There is now a great thirst for knowledge on this subject, among healthcare professionals and consumers. The promise of stem cell therapies involve the potential replacement of cells or organs that are diseased, injured, infirm, ailing or aged. There has been a degree of “hype” about stem cells in some popular media formats, where putative claims of benefit may have transcended current science. In this stem cell summit, a group of experienced academics and individuals, involved in stem cell transplantation, present a series of topics to cover the general principles and practice of stem cell biology and evidence-based treatments. There is no doubt that stem cell treatments afford an enticing pathway for the promotion of longevity, but outcome data in this area remain limited. |
|
TARGETS AND OBJECTIVES
To provide a basic overview of research and
current clinical application of stem cell treatments.
To educate participants on an evidenced-based
approach of referral of patients for evaluation
for stem cell therapies, with respect to peer-
reviewed literature.
To understand the basic organizational structure
of a clinical, operating, stem cell facility, with
reporting of outcome data.
To attempt to sort science from speculation
in the field of stem cell science.
To develop a working knowledge of the ethics and
regulatory practices that govern the use of stem
cells taken from a variety of sources, including:
embryonic, adult, (ip) and cord-blood stem cells.
To understand the potential value of
stem cell banking.
To develop a knowledge base which can provide
a physician with guidance in counseling
patients who inquire about stem cell treatments.
To place stem cell therapies in their correct
perspective in clinical practice.
| |
|
| |
|
There is a tremendous need for knowledge in Stem Cell Therapy Call Today!
|
This email was sent to: hgc1123@hanmail.net This is a commercial message from A4M, Inc. in full compliance with Federal regulation. Not interested in receiving conference announcements from A4M? click here to be removed from our mailing list. |
|
A4M: 301 Yamato Road, Boca Raton, FL 33431
| | |
|
|
 |
|
Key to Obesity?
 Cut out sugar. Eat lots of protein. Hit the gym to peel off pounds. Chug water before meals. Here's a new one: What if none of it works? Losing weight has long been our national obsession, and never more so than at the start of a new year. But for all the diets we've tried, and the fortunes spent on the multibillion-dollar diet industry, more than 72 million American adults are obese. Obesity-related health problems such as diabetes, heart disease and high blood pressure add as much as $140 billion to our annual medical bills.
Continue Reading
Amish prove clean living pays off
 U.S. researchers say an examination of cancer rates among the Amish underscores the virtues of exercise, not smoking, healthy food and fewer sex partners.
Researchers at the Ohio State University's James Cancer Hospital and Solove Research Institute in Columbus say they were not surprised tobacco-related cancers were 63 percent lower among the non-smoking Amish than in the non-Amish.
Continue Reading
Endocrine Aspects of Women's Sexual Function
 ABSTRACT: Introduction. Endocrine changes during aging as well as endocrine disorders may either directly or indirectly modulate female sexual function by altering sex hormones, or by impacting on vascular, neurogenic, or psychologic factors.
Aim. To review information on the impact of the hormonal changes associated with aging or those caused by endocrine disorders on female sexual function and current information on the risks and benefits of hormonal treatments.
Methods. Committee members outlined topics and reviewed the published literature on endocrine aspects of female sexual function over a 2-year period. Presentation of the recommendations were presented at the International Consultation on Sexual Medicine Paris, France 2009 and revised accordingly.
Continue Reading
Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men - Abstract
 Study Type - Prognosis (inception cohort) Level of Evidence 2b
To evaluate serum sex steroid hormone concentrations and long-term risk of subsequent lower urinary tract symptoms (LUTS) in a cohort of community-dwelling older men.
Between 1984 and 1987, serum sex hormone concentrations were measured in participants in the Rancho Bernardo Study, a prospective, community-based study. In 2006, the American Urological Association Symptom Index (AUA-SI) was mailed to surviving male participants. Logistic regression was used to examine associations of baseline hormone concentrations with AUA-SI.
Continue Reading
Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation
 GH levels increase to high concentrations immediately before puberty then progressively decline with age. GH deficiency (GHD) originating in childhood is treated with GH supplementation to foster somatic development during adolescence. It is not clear if or how early GH replacement affects memory in adulthood, or whether it can prevent the cognitive deficits commonly observed in adults with childhood-onset GHD. Rats homozygous for the Dw-4 mutation (dwarf) do not exhibit the normal increase in GH at 4 weeks of age when GH levels normally rise and are used to model childhood or early-onset GHD (EOGHD). One group of these rats was injected with GH from 4 to 14 weeks of age to model GH supplementation during adolescence with GHD beginning in adulthood (adult-onset GHD; AOGHD).
Continue Reading
| |
| |
|
This information is made available to Medaus Newsletter Subscribers.
|
|
|
등급 )
